75. Cushing disease Clinical trials / Disease details
Clinical trials : 203 / Drugs : 191 - (DrugBank : 51) / Drug target genes : 62 - Drug target pathways : 128
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02484755 (ClinicalTrials.gov) | June 2015 | 21/6/2015 | Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease | Targeted Therapy With Gefitinib in Patients With USP8-mutated Cushing's Disease | Cushing's Disease;Corticotrophin Adenoma | Drug: Gefitinib | Huashan Hospital | NULL | Recruiting | 18 Years | 70 Years | Both | 6 | Phase 2 | China |